These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Crohn's disease: no advantage by azathioprine and 6-mercaptopurine]. Schreiber S. Dtsch Med Wochenschr; 2013 Sep; 138(38):1877. PubMed ID: 24022448 [No Abstract] [Full Text] [Related]
4. [Invasive cancer of the cervix in a patient undergoing chronic treatment with 6-mercaptopurine for Crohns disease]. Alvarez Delgado A, Pérez García ML, Fradejas Salazar PM, de la Coba Ortíz C, Rodríguez Pérez A. Gastroenterol Hepatol; 2003 Jan; 26(1):52-3. PubMed ID: 12525330 [No Abstract] [Full Text] [Related]
5. [When is drug therapy with azathioprine indicated in Crohn's disease?]. Rogler G, Herfarth H. Dtsch Med Wochenschr; 2002 May 31; 127(22):1213-4. PubMed ID: 12035120 [No Abstract] [Full Text] [Related]
6. 6-Mercaptopurine and other immunosuppressive agents in the treatment of Crohn's disease and ulcerative colitis. Present DH. Gastroenterol Clin North Am; 1989 Mar 31; 18(1):57-71. PubMed ID: 2646222 [Abstract] [Full Text] [Related]
7. Azathioprine pancreatitis in inflammatory bowel disease and successful subsequent treatment with mercaptopurine. Alexander S, Dowling D. Intern Med J; 2005 Sep 31; 35(9):570-1. PubMed ID: 16105163 [No Abstract] [Full Text] [Related]
8. Immunosuppressive therapy of inflammatory bowel disease: a historical perspective. Korelitz BI. Gastroenterologist; 1995 Jun 31; 3(2):141-52. PubMed ID: 7640945 [Abstract] [Full Text] [Related]
9. Immunosuppressive drugs in Crohn's disease. Kornbluth A, George J, Sachar DB. Gastroenterologist; 1994 Sep 31; 2(3):239-46. PubMed ID: 7987622 [Abstract] [Full Text] [Related]
10. Azathioprine and 6-mercaptopurine for Crohn's disease. Lancet; 1980 Aug 09; 2(8189):298-9. PubMed ID: 6105443 [No Abstract] [Full Text] [Related]
11. Successful desensitization to 6-mercaptopurine in a patient with Crohn's disease. Mutinga M, Castells M, Horan R, Farraye FA. Am J Gastroenterol; 2000 May 09; 95(5):1383-4. PubMed ID: 10811376 [No Abstract] [Full Text] [Related]
12. Therapeutic efficacy and safety of 6-mercaptopurine and azathioprine in patients with Crohn's disease. Markowitz JF. Rev Gastroenterol Disord; 2003 May 09; 3 Suppl 1():S23-9. PubMed ID: 12684586 [Abstract] [Full Text] [Related]
13. Serum sickness associated with 6-mercaptopurine in a patient with Crohn's disease. Andersen JM, Tiede JJ. Pharmacotherapy; 1997 May 09; 17(1):173-6. PubMed ID: 9017780 [Abstract] [Full Text] [Related]
14. Immunosuppressants and Crohn's disease. Goldstein F. Gastroenterology; 1972 May 09; 62(5):1101-2. PubMed ID: 5029074 [No Abstract] [Full Text] [Related]
15. [Immunosuppressive treatment of Crohn's disease]. Kasper H, Auer I. Dtsch Z Verdau Stoffwechselkr; 1976 May 09; 36(3-4):143-5. PubMed ID: 1021382 [No Abstract] [Full Text] [Related]
17. [Myelotoxicity due to interaction between azathioprine and allopurinol in a patient with Crohn's disease]. Millán M, Castro-Fernández M, Ampuero J, Romero-Gómez M. Gastroenterol Hepatol; 2013 Apr 09; 36(4):298-9. PubMed ID: 23274032 [No Abstract] [Full Text] [Related]
18. Azathioprine and 6-mercaptopurine for the prevention of postoperative recurrence in Crohn's disease: a meta-analysis. Peyrin-Biroulet L, Deltenre P, Ardizzone S, D'Haens G, Hanauer SB, Herfarth H, Lémann M, Colombel JF. Am J Gastroenterol; 2009 Aug 09; 104(8):2089-96. PubMed ID: 19568226 [Abstract] [Full Text] [Related]
19. [Immunosuppressive treatment and Crohn's disease]. Delwaide J, Louis E, Gast P, Belaiche J. Rev Med Liege; 1991 Jan 09; 46(1):22-8. PubMed ID: 2011678 [No Abstract] [Full Text] [Related]
20. Pancreatitis in inflammatory bowel diseases. Pitchumoni CS, Rubin A, Das K. J Clin Gastroenterol; 2010 Apr 09; 44(4):246-53. PubMed ID: 20087199 [Abstract] [Full Text] [Related] Page: [Next] [New Search]